PetMed Express, Inc. (PETS)

PetMed Express received Nasdaq non-compliance notices due to delayed financial report filings. Preliminary fiscal Q2 2026 results showed a decrease in net sales, and an analysis of a goodwill impairment was noted. The company received unsolicited acquisition proposals from SilverCape Investments Limited and Cardone Ventures, LLC. Sandra Campos resigned as CEO, and Leslie C. Campbell was named Interim CEO and President. A strategic partnership with Rural King was announced to expand its customer base. The company's stock price has declined, with mixed investor sentiment following the Q1 2026 earnings release.

Demand for pet medications and veterinary services exhibits seasonality, with higher revenue in the first, second, and third quarters compared to the fourth quarter. The first quarter accounts for approximately 27.9% of veterinary practice revenue, the second quarter accounts for approximately 28.6%, the third quarter accounts for approximately 24.9%, and the fourth quarter accounts for about 18.5%. Demand for parasiticide products spikes seasonally during warmer months.

PetMed Express, Inc., operating as PetMeds and PetCareRx, is a direct-to-consumer pet pharmacy founded in 1996. The company offers a wide range of prescription and non-prescription pet medications, health products, and supplies for dogs, cats, and horses, with over 15,000 SKUs. Revenue is generated through online platforms, mobile apps, customer support, and direct mail.

PetMed Express operates as a national online pharmacy, licensed in all 50 U.S. states. Its fulfillment center is located in Delray Beach, Florida, and its subsidiary, PetCareRx, is in Lynbrook, New York. The company primarily serves customers in the United States, with some offerings available in Canada.

PetMed Express's brand reputation has faced challenges due to an internal investigation triggered by a whistleblower complaint regarding revenue recognition and a shareholder lawsuit investigation focusing on potential misleading financial information. Nasdaq non-compliance notices could negatively impact investor confidence. The strategic partnership with Rural King could positively impact the company's reputation by expanding its reach.

Institutional investors hold a significant portion of PetMed Express's shares, ranging from approximately 14.15% to 78%. Major institutional owners include Renaissance Technologies Llc, Vanguard Group Inc, and BlackRock, Inc. Individual investors also hold a notable percentage of the stock. Insider holdings are reported to be under 3%. Silvercape Investments Ltd. and Nina Capital Holdings Inc. are also listed as significant shareholders.